Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine versus cold normal saline for reducing propofol injection pain
IRCT20141121020020N7Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of lidocaine, Normal Saline-Benha University and propofol (3 arms), sponsored by Babol University of Medical Sciences. Primary endpoint: Change in amount of pain at the injection site of propofol. Started Mar 2021; status: completed.
02
Drugs
lidocaineNormal Saline-Benha Universitypropofol
Beyond the preview
Go deeper on IRCT20141121020020N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141121020020N7.